Immunocore Holdings plc (IMCR) Tops Q3 EPS by 10c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
Immunocore Holdings (IMCR) PT Raised to $85 at Cowen
November 9, 2022 10:42 AM ESTCowen analyst Tyler Van Buren raised the price target on Immunocore Holdings (NASDAQ: IMCR) to $85.00 (from $80.00) while maintaining a Outperform rating.
The analyst commented, "Kimmtrak posted a strong quarter with a 15% beat vs. us/consensus. Mgmt stated that duration of treatment is... More



